Glenmark Pharmaceuticals Ltd Dividend History

Glenmark Pharmaceuticals Ltd declared a dividend of ₹2.50 per share on 29 May 2026, with a record date of 31 Aug 2026.

To receive the Glenmark Pharmaceuticals Ltd dividend, you must hold GLENMARK shares before the ex-date of 31 Aug 2026. Under T+1 settlement, buying on the ex-date itself makes you ineligible. The dividend is credited to your linked bank account within 30 days of the record date.

Glenmark Pharmaceuticals Ltd pays multiple dividends per financial year — both interim and final.

Glenmark Pharmaceuticals Ltd's current dividend yield is 0.20%. This is relatively low — Glenmark Pharmaceuticals Ltd is primarily a capital appreciation stock rather than a high-dividend one.

Dividends from Glenmark Pharmaceuticals Ltd are taxable as income from other sources at your applicable income tax slab rate. TDS at 10% is deducted at source if your total dividend income from Glenmark Pharmaceuticals Ltd exceeds ₹10,000 in a financial year. NRI investors are subject to 20% TDS or applicable DTAA rate. You can claim TDS credit when filing your ITR.